Daclizumab is Associated With Decreased Rejection and No Increased Mortality in Cardiac Transplant Patients Receiving MMF, Cyclosporine, and Corticosteroids

✍ Scribed by J. Kobashigawa; K. David; J. Morris; A.H. Chu; B.J. Steffen; V.P. Gotz; R.D. Gordon

• Book ID: 116930749
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 305 KB
• Volume: 37
• Category: Article
• ISSN: 0041-1345
• DOI: 10.1016/j.transproceed.2004.12.135